Weaver Family Holdings Limited 30/09/2021 iXBRL
Weaver Family Holdings Limited 30/09/2021 iXBRL
Company registration number:
03600349
Contents
Abridged statement of financial position
Notes to the financial statements
Abridged statement of financial position
30 September 2021
2021 | 2020 | ||||||||
Note | £ | £ | £ | £ | |||||
Fixed assets | |||||||||
Investments | 4 |
|
|
||||||
_______ | _______ | ||||||||
|
|
||||||||
Current assets | |||||||||
Debtors |
|
|
|||||||
_______ | _______ | ||||||||
|
|
||||||||
Net current assets |
|
|
|||||||
_______ | _______ | ||||||||
Total assets less current liabilities |
|
|
|||||||
_______ | _______ | ||||||||
Net assets |
|
|
|||||||
_______ | _______ | ||||||||
Capital and reserves | |||||||||
Called up share capital |
|
|
|||||||
Profit and loss account |
|
|
|||||||
_______ | _______ | ||||||||
Shareholders funds |
|
|
|||||||
_______ | _______ | ||||||||
Directors responsibilities:
-
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
-
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
In accordance with section 444 of the Companies Act 2006, the abridged statement of comprehensive income has not been delivered.
These financial statements were approved by the
board of directors
and authorised for issue on
29 June 2022
, and are signed on behalf of the board by:
Director
Company registration number:
03600349
Notes to the financial statements
Year ended 30 September 2021
1.
General information
The company is a private company limited by shares, registered in England. The address of the registered office is 40 Hartopp Road, Sutton Coldfield, West Midlands, B74 2QR.
2.
Statement of compliance
3.
Accounting policies
Basis of preparation
Consolidation
Taxation
Fixed asset investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses. Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Impairment
Financial instruments
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4.
Investments
£ | ||
Cost | ||
At 1 October 2020 and 30 September 2021 |
|
|
_______ | ||
Impairment | ||
At 1 October 2020 and 30 September 2021 | - | |
_______ | ||
Carrying amount | ||
At 30 September 2021 |
|
|
_______ | ||
At 30 September 2020 |
|
|
_______ | ||